Stringent response is a physiological mechanism utilized by bacteria to adapt to nutrient deprivation and many other stresses. In Borrelia burgdorferi (Bb), the etiological agent of Lyme disease, stringent response is mediated by both the alarmone nucleotides (p)ppGpp and the RNA polymerase-binding protein DksA. Recently, we found that DksA plays an essential role in regulating Bb's virulence. First, dksA is highly expressed in infected animals and is required by Bb to infect the mammalian hosts. Second, DksA is critical for Bb's optimal growth. Third, DksA is required by Bb to cope with metabolic stress. Finally, in addition to function as a stringent response regulator, DksA promotes the transcription and/or translation of genes contributing to Bb's survival in the host. These combined data give rise to our hypothesis that DksA is a master regulator governing Bb's virulence gene expression. This hypothesis will be addressed in two Specific Aims.
In Aim 1 of this proposal, we will determine the contribution of DksA to Bb's survival and persistence in ticks.
In Aim 2, we will identify genes regulated by DksA under various in vitro and in vivo conditions. These combined studies will (i) define the entire DksA regulon; and (ii) provide a transformative understanding of the in vivo importance of DksA and the regulon. Resultant findings could lead to the development of new strategies to prevent and/or treat Lyme disease.

Public Health Relevance

Lyme disease is the most common arthropod-borne illness in the United States. The causative agent, Borrelia burgdorferi, maintains itself in nature through a complex tick-mammal life cycle involving an Ixodes tick vector and mammalian hosts. This study will elucidate molecular components critical for the parasitic strategies of B. burgdorferi, which will provide new modalities for the development of innovative disease intervention strategies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21AI159061-01
Application #
10189812
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Ilias, Maliha R
Project Start
2021-03-19
Project End
2023-02-28
Budget Start
2021-03-19
Budget End
2022-02-28
Support Year
1
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of South Florida
Department
Biochemistry
Type
Schools of Medicine
DUNS #
069687242
City
Tampa
State
FL
Country
United States
Zip Code
33617